Matthew Ros

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Ros:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verastem, Inc. Chief Operating Officer Common Stock 50,000 $352,000 $7.04 01 Apr 2025 Direct
Cogent Biosciences, Inc. Director Stock Option (Right to Buy) 44,700 $321,187 $7.19 04 Jun 2025 Direct
Epizyme, Inc. Executive Vice President, Chief Strategy & Business Officer Common Stock, par value $0.0001 111,313 $156,951 $1.41 16 Aug 2021 Direct
Epizyme, Inc. Executive Vice President, Chief Strategy & Business Officer Stock Option (Right to Buy) 134,178 $75,140 $0.5600 16 Aug 2021 Direct

Insider Reports Filed by Matthew Ros

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COGT Cogent Biosciences, Inc. 04 Jun 2025 1 $0 4 Director 05 Jun 2025, 16:21
VSTM Verastem, Inc. 01 Apr 2025 1 $0 4 Chief Operating Officer 03 Apr 2025, 16:30
VSTM Verastem, Inc. 14 Jan 2025 0 $0 3 Chief Operating Officer 21 Jan 2025, 16:30
COGT Cogent Biosciences, Inc. 05 Jun 2024 1 $0 4 Director 13 Jun 2024, 19:14
COGT Cogent Biosciences, Inc. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 16:20
COGT Cogent Biosciences, Inc. 02 Oct 2023 1 $0 4 Director 03 Oct 2023, 16:56
COGT Cogent Biosciences, Inc. 03 Jul 2023 1 $0 4 Director 05 Jul 2023, 16:53
COGT Cogent Biosciences, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:41
COGT Cogent Biosciences, Inc. 03 Apr 2023 1 $0 4 Director 04 Apr 2023, 16:15
COGT Cogent Biosciences, Inc. 03 Jan 2023 1 +$12,876 4 Director 04 Jan 2023, 15:31
COGT Cogent Biosciences, Inc. 03 Oct 2022 1 +$12,879 4 Director 04 Oct 2022, 16:35
COGT Cogent Biosciences, Inc. 01 Jul 2022 1 +$12,880 4 Director 05 Jul 2022, 13:51
COGT Cogent Biosciences, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 17:09
COGT Cogent Biosciences, Inc. 01 Apr 2022 1 +$12,879 4 Director 05 Apr 2022, 16:05
COGT Cogent Biosciences, Inc. 03 Jan 2022 1 +$11,625 4 Director 04 Jan 2022, 20:24
COGT Cogent Biosciences, Inc. 01 Oct 2021 1 +$12,393 4 Director 05 Oct 2021, 19:11
/report/000089924321033402-ros-matthew-2021-08-16 Epizyme, Inc. 16 Aug 2021 2 $0 4 Executive Vice President, Chief Strategy & Business Officer 18 Aug 2021, 08:02
COGT Cogent Biosciences, Inc. 01 Jul 2021 1 +$10,625 4 Director 06 Jul 2021, 19:08